Inflammation as a sensor of metabolic stress in obesity and type 2 diabetes

Endocrinology

Volumn 152, Issue 11, 2011, Pages 4005-4006

  Donath, Marc Y ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1BETA;

FAT INTAKE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; METABOLIC STRESS; MOLECULAR MECHANICS; MOLECULAR SENSOR; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; CARRIER PROTEINS; CYTOSKELETAL PROTEINS; INFLAMMASOMES; OBESITY; PANCREAS;

EID: 80054921854     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2011-1691     Document Type: Short Survey

References (17)

1. Donath MY, Shoelson SE 2011 Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98-107
2. Youm YH, Adijiang A, Vandanmagsar B, Burk D, Ravussin A, Dixit VD 2011 Elimination of the NLRP3-ASC inflammasome protects against chronic obesity-induced pancreatic damage. Endocrinology 152:4039-4045
3. Böni-Schnetzler M, Boller S, Debray S, Bouzakri K, Meier DT, Prazak R, Kerr-Conte J, Pattou F, Ehses JA, Schuit FC, Donath MY 2009 Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology 150:5218-5229
4. Maedler K, Sergeev P, Ris F, Oberholzer J, Joller-Jemelka HI, Spinas GA, Kaiser N, Halban PA, Donath MY 2002 Glucose-induced β-cell production of interleukin-1β contributes to glucotoxicity in human pancreatic islets. J Clin Invest 110:851-860
5. Masters SL, Dunne A, Subramanian SL, Hull RL, Tannahill GM, Sharp FA, Becker C, Franchi L, Yoshihara E, Chen Z, Mullooly N, Mielke LA, Harris J, Coll RC, Mills KH, Mok KH, Newsholme P, Nuñez G, Yodoi J, Kahn SE, Lavelle EC, O'Neill LA 2010 Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol 11:897-904
6. Westwell-Roper C, Dai DL, Soukhatcheva G, Potter KJ, van Rooijen N, Ehses JA, Verchere CB 2011 IL-1 blockade attenuates islet amyloid polypeptide-induced proinflammatory cytokine release and pancreatic islet graft dysfunction. J Immunol 187:2755-2765
7. Larsen CM, Faulenbach M, Vaag A, Vølund A, Ehses JA, Seifert B, Mandrup-Poulsen T, Donath MY 2007 Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N Engl J Med 356:1517-1526 (Pubitemid 46588416)
8. van Asseldonk EJ, Stienstra R, Koenen TB, Joosten LA, Netea MG, Tack CJ 2011 Treatment with Anakinra improves disposition index but not insulin sensitivity in nondiabetic subjects with the metabolic syndrome: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 96:2119-2126
9. Martinon F, Pétrilli V, Mayor A, Tardivel A, Tschopp J 2006 Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440:237-241 (Pubitemid 43372104)
10. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E 2010 NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357-1361
11. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J 2010 Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11:136-140
12. Stienstra R, Joosten LA, Koenen T, van Tits B, van Diepen JA, van den Berg SA, Rensen PC, Voshol PJ, Fantuzzi G, Hijmans A, Kersten S, Müller M, van den Berg WB, van Rooijen N, Wabitsch M, Kullberg BJ, van der Meer JW, Kanneganti T, Tack CJ, Netea MG 2010 The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab 12:593-605
13. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, Dixit VD 2011 The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17:179-188
14. Wen H, Gris D, Lei Y, Jha S, Zhang L, Huang MT, Brickey WJ, Ting JP 2011 Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat Immunol 12:408-415
15. Ehses JA, Lacraz G, Giroix MH, Schmidlin F, Coulaud J, Kassis N, Irminger JC, Kergoat M, Portha B, Homo-Delarche F, Donath MY 2009 IL-1 antagonism reduces hyperglycemia and tissue inflammation in the type 2 diabetic GK rat. Proc Natl Acad Sci USA 106:13998-14003
16. Sauter NS, Schulthess FT, Galasso R, Castellani LW, Maedler K 2008 The antiinflammatory cytokine interleukin-1 receptor antagonist protects from high-fat diet-induced hyperglycemia. Endocrinology 149:2208-2218 (Pubitemid 351574505)
17. Fleischman A, Shoelson SE, Bernier R, Goldfine AB 2008 Salsalate improves glycemia and inflammatory parameters in obese young adults. Diabetes Care 31:289-294 (Pubitemid 351213338)